Integra LifeSciences IART Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's investing cash flow?
- Integra LifeSciences (IART) reported investing cash flow of -$14.85M in Q1 2026.
- How has Integra LifeSciences's investing cash flow changed year-over-year?
- Integra LifeSciences's investing cash flow increased by 58.7% year-over-year, from -$35.92M to -$14.85M.
- What is the long-term trend for Integra LifeSciences's investing cash flow?
- Over 3 years (2021 to 2025), Integra LifeSciences's investing cash flow has grown at a -12.5% compound annual growth rate (CAGR), from -$161.44M to -$108.06M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.